Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology

July 8, 2019 – Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by the Society of Cardiovascular Computed Tomography (SCCT). Leipsic will present the second Dehaan Award Lecture at the SCCT 14th Annual Scientific Meeting, July 11-14 in Baltimore. The award, presented by the Jon DeHaan Foundation, includes a $200,000 grant.

Leipsic is the chairman of the department of radiology for Providence Health Care and the vice-chairman of research and a professor of radiology and cardiology for the University of British Columbia. He is a past president of the SCCT (2015-2016) and will also be awarded the SCCT Gold Medal Award in 2019.

Read the article "SCCT Announces 2019 Gold Medal Award Recipients"

“Dr. Leipsic has been a tireless champion, teacher and leader in cardiac applications of CT for many years. He has devoted countless hours toward advancing the field, and at the same time has thus touched many patients multiplied by the number of cardiologists who have used his work or who have learned from him directly.” said Robert Schwartz, M.D., chairman of the board for the Jon DeHaan Foundation. “It is a great pleasure that Dr. Leipsic has been chosen for the Jon H. DeHaan Foundation award for cardiovascular excellence in imaging, the purpose of which is to further his work and teaching, thus advancing cardiac CT far into the future.”

Leipsic intends to build on past work delving into the mechanisms of bioprosthetic valve failure. The data suggests that the mechanisms and timelines of valve degeneration are consistent across surgical and transcatheter bioprosthetic heart valves, and a better understanding of structural valve degeneration can be obtained through combining further histological and novel imaging approaches. Leipsic will continue along this path of investigation through the generous support of the DeHaan Foundation Award, which will allow him to perform the needed advanced analyses to help advance understanding of this complex process and potentially develop solutions to this important clinical problem.

The award lecture at the SCCT Annual Scientific Meeting, generously supported by the Jon Holden DeHaan Foundation, helps promote the knowledge and the use of cardiovascular CT to improve patient outcomes.

For more information: www.scct.org

SCCT Releases New Guideline for CT Use During TAVR

Related Content

News | Nuclear Imaging | June 01, 2020

Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels

June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a

Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020

CT Findings of Coronavirus in Children Often Negative

May 29, 2020 — An investigation published open-access in the ...

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020

FDA Clears Philips Ultrasound Portfolio to Image COVID-19 Related Lung and Cardiac Complications

May 26, 2020 — Philips Healthcare recently received 510(k) clearance from the U.S.

$An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.$

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020

DiA Imaging Analysis Receives Grant to Accelerate Access Ultrasound AI in Fight Against COVID-19

May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm

Extends access of AI software that supports chest imaging, including CT and X-ray, to U.S. radiologists at over 7,000 healthcare facilities

News | Coronavirus (COVID-19) | May 21, 2020

RADLogics’ AI-Powered Applications Supporting the Evaluation of COVID-19 Patients are Now Available on Nuance AI Marketplace

May 21, 2020 — ...

Examples of chest CT images of COVID-19 (+) patients and visualization of features correlated to COVID-19 positivity. For each pair of images, the left image is a CT image showing the segmented lung used as input for the CNN (convolutional neural network algorithm) model trained on CT images only, and the right image shows the heatmap of pixels that the CNN model classified as having SARS-CoV-2 infection (red indicates higher probability). (a) A 51-year-old female with fever and history of exposure to SARS-

Figure 1: Examples of chest CT images of COVID-19 (+) patients and visualization of features correlated to COVID-19 positivity. For each pair of images, the left image is a CT image showing the segmented lung used as input for the CNN (convolutional neural network algorithm) model trained on CT images only, and the right image shows the heatmap of pixels that the CNN model classified as having SARS-CoV-2 infection (red indicates higher probability). (a) A 51-year-old female with fever and history of exposure to SARS-CoV-2. The CNN model identified abnormal features in the right lower lobe (white color), whereas the two radiologists labeled this CT as negative. (b) A 52-year-old female who had a history of exposure to SARS-CoV-2 and presented with fever and productive cough. Bilateral peripheral ground-glass opacities (arrows) were labeled by the radiologists, and the CNN model predicted positivity based on features in matching areas. (c) A 72-year-old female with exposure history to the animal market in Wuhan presented with fever and productive cough. The segmented CT image shows ground-glass opacity in the anterior aspect of the right lung (arrow), whereas the CNN model labeled this CT as negative. (d) A 59-year-old female with cough and exposure history. The segmented CT image shows no evidence of pneumonia, and the CNN model also labeled this CT as negative.

News | Coronavirus (COVID-19) | May 19, 2020

Mount Sinai First in U.S. to Use AI to Analyze Coronavirus Patients

May 19, 2020 — Mount Sinai researchers are the first in the country to use...